We are live on ! Find out more
ARTL icon

Artelo Biosciences
ARTL

16 hedge funds and large institutions have $3.29M invested in Artelo Biosciences in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

52% more capital invested

Capital invested by funds: $2.17M → $3.29M (+$1.12M)

33% more funds holding

Funds holding: 12 → 16 (+4)

3.51% more ownership

Funds ownership: 8.47% → 11.97% (+3.5%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
16
Holders Change
+4
Holders Change %
+33.33%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$778K
2
Renaissance Technologies
Renaissance Technologies
New York
+$704K
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$329K
4
Two Sigma Investments
Two Sigma Investments
New York
+$206K
5
HighTower Advisors
HighTower Advisors
Illinois
+$80K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$166K
2
Citadel Advisors
Citadel Advisors
Florida
-$132K
3
Jane Street
Jane Street
New York
-$34K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$18.5K

ARTL Hedge Fund Activity: Q2 2021 in Review

16 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q2 2021, worth a combined $3.29M — up 52% from $2.17M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ARTL positions and 1 closed out — a net gain of 4 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $778K. The largest seller was Virtu Financial, cutting an estimated $166K.

  • 16 institutional investors held Artelo Biosciences (ARTL) as of Q2 2021, up from 12 in Q1 2021.
  • Funds reported $3.29M of Artelo Biosciences stock for Q2 2021, up 52% quarter-over-quarter.
  • 5 funds opened new Artelo Biosciences positions in Q2 2021 and 1 closed out, a net change of +4 holders.
  • The largest Artelo Biosciences buyer in Q2 2021 was Vanguard Group, an estimated $778K added.
  • The largest Artelo Biosciences seller in Q2 2021 was Virtu Financial, an estimated $166K sold.

Based on aggregated 13F filings for Q2 2021.